Views: 0 Author: Site Editor Publish Time: 2026-08-06 Origin: Site
Ashwagandha (Withania somnifera) is an adaptogenic herb with centuries of use in traditional Ayurvedic medicine. Modern research suggests it may help reduce stress and anxiety, improve sleep quality, and support cognitive function. A 2024 meta-analysis of 9 randomized controlled trials involving 558 patients found that ashwagandha significantly reduced perceived stress (by an average of 4.72 points on the Perceived Stress Scale), anxiety (by 2.19 points on the Hamilton Anxiety Scale), and serum cortisol levels compared to placebo . For sleep, evidence shows small but meaningful improvements, particularly at doses of 600 mg/day for at least 8 weeks .
But here’s the nuance that most brands miss — and it’s the difference between a product that delivers real value and one that contributes to consumer skepticism: not all ashwagandha extracts are created equal. The withanolide content varies widely (typically 1.5% to 10%), the extraction source matters (root vs. leaf vs. combination), the bioavailability of different branded ingredients varies significantly, and most clinical studies have been conducted on specific proprietary extracts — not generic powders.
Below, we break down the science, the benefits, the formulation choices, and what brands need to know — from a manufacturer’s perspective.
Ashwagandha (Withania somnifera) is an evergreen shrub cultivated in tropical and subtropical regions of Asia, Africa, and Europe. Its name comes from Sanskrit — “ashwa” for horse and “gandha” for smell — referring to the root’s distinctive odor. The species name “somnifera” is Latin for “sleep-inducing,” reflecting one of its traditional uses .
The primary bioactive compounds in ashwagandha are steroidal lactones known as withanolides. Over 40 different withanolides have been identified, including withanoside IV and V, withanolide A–D, withanone, and withaferin-A. These compounds are believed responsible for most of ashwagandha’s adaptogenic and therapeutic effects. The United States Pharmacopoeia (USP) recognizes seven specific withanolide peaks for quality standardization .
Ashwagandha also contains alkaloids and flavonoids that may contribute to its biological activity, though withanolides remain the primary standardization marker for commercial extracts .
In traditional Ayurvedic and Unani medicine, ashwagandha has been used for over 4,000 years as a “Medharasayan” — a category of substances that promote learning and memory retrieval. It is described as an adaptogen, meaning it is thought to help the body resist, adapt to, and recover from biological, physical, and chemical stressors .
This is the most well-established benefit of ashwagandha. A 2024 systematic review and meta-analysis published in Complementary Therapies in Medicine analyzed 9 randomized controlled trials involving 558 patients. The findings showed :
Outcome Measure | Average Improvement vs. Placebo |
|---|---|
Perceived Stress Scale (PSS) | -4.72 points |
Hamilton Anxiety Scale (HAS) | -2.19 points |
Serum Cortisol | -2.58 units |
A 2021 systematic review of 7 studies (491 participants, all from India) also found that ashwagandha extracts significantly reduced stress and anxiety, with benefits appearing greater at doses of 500–600 mg/day compared to lower doses .
225 mg/day vs. 400 mg/day (NooGandha) : A Florida-based study with 60 adults found both doses improved stress, anxiety, depression, and food cravings. The 225-mg dose also reduced salivary cortisol .
300 mg/day sustained-release (Prolanza) : 130 adults in India reported improvements in stress, sleep quality, psychological well-being, memory, and focus over 90 days .
125 mg/day (Zenroot™) : A 2025 study published in Advances in Therapy found that this lower-dose formulation significantly reduced stress, anxiety, and sleep disturbances over 84 days, with no safety concerns. The Zenroot formulation showed 2.1-fold higher bioavailability compared to a 600-mg, 5% withanolide commercial product .
500 mg/day with piperine (Shagandha) : 54 participants with mild-to-moderate stress and anxiety showed significant reductions in stress and anxiety scores at day 60 .
WFSBP/CANMAT Recommendation: An international taskforce from the World Federation of Societies of Biological Psychiatry and the Canadian Network for Mood and Anxiety Treatments provisionally recommends 300–600 mg/day of ashwagandha root extract (standardized to 5% withanolides) for generalized anxiety disorder, noting that more data is needed for a stronger recommendation .
Evidence supports small but meaningful improvements in sleep. A 2021 systematic review and meta-analysis of 5 studies (372 participants) found that ashwagandha extract had a small but significant effect on improving sleep compared to placebo. Benefits were more prominent at 600 mg/day and with treatment duration of at least 8 weeks .
Sleep Outcome | Finding |
|---|---|
Sleep quality | 72% improvement in ashwagandha group vs. 29% in placebo group |
Sleep efficiency | Improved significantly |
Sleep latency | Decreased (fell asleep faster) |
Total sleep time | Increased |
Benefits were more pronounced in participants with insomnia .
Studies have reported improvements in memory, focus, and concentration among ashwagandha users. Participants in several trials noted enhanced mental clarity and multitasking ability. However, more research is needed to confirm these effects independently from stress reduction benefits .
Some studies suggest ashwagandha may improve muscle strength, endurance, and recovery. One study cited by MSD Manuals reported significant improvements in bench-press power, squats, and recovery scores among participants taking ashwagandha . This makes it a potential addition to sports nutrition formulations, though the evidence base is more limited than for stress and sleep.
The following claims have been made but require more research to confirm:
Proposed Benefit | Evidence Status |
|---|---|
Reduced inflammation | Preliminary |
Lowered cholesterol/triglycerides | Limited |
Lowered blood pressure | Limited |
Reduced blood sugar in diabetics | Limited |
Male fertility support | Traditional use, limited clinical evidence |
Notable: The MSD Manuals Consumer Version notes that “any single compound, including ashwagandha, is highly unlikely to have such a broad range of health benefits” as often claimed, and larger studies are needed to confirm these benefits .
Ashwagandha appears well-tolerated for up to about 3 months of use. Common side effects are usually mild :
Upset stomach / digestive discomfort
Loose stools / diarrhea
Nausea
Drowsiness / sedation
Headache
Liver injury: There are reports of liver dysfunction associated with ashwagandha use. A 2017 report described a 20-year-old man in Japan who developed liver dysfunction and hyperbilirubinemia after using ashwagandha in combination with other supplements .
Thyroid effects: Ashwagandha may affect thyroid function and could interact with thyroid medications .
Hormonal effects: Ashwagandha may increase testosterone levels, which could adversely affect hormone-dependent prostate cancer .
Population | Reason |
|---|---|
Pregnant women | Possible abortifacient effects |
Breastfeeding women | Lack of safety data |
People with prostate cancer | May increase testosterone |
People with liver disease | Potential liver effects |
People with stomach ulcers | May worsen gastric irritation |
Long-term safety is not yet established, and evidence on using ashwagandha over many months or years is lacking .
Ashwagandha extracts are standardized by withanolide percentage. Common standards include:
Standardization | Typical Extract Ratio | Common Doses | Clinical Evidence |
|---|---|---|---|
1.5% withanolides | 50:1 | 125 mg | 2025 Zenroot study |
2.5% withanolides | 10:1 | 500 mg | Shagandha study |
5% withanolides | 10:1 | 300–600 mg | Most clinical studies, WFSBP recommendation |
10% withanolides | Higher potency | Variable | Less clinical data |
Key consideration: Lower withanolide content doesn’t automatically mean lower efficacy — bioavailability matters. The 2025 Zenroot study found 125 mg of 1.5% withanolide formulation outperformed 600 mg of 5% withanolide product due to enhanced bioavailability .
Ashwagandha supplements typically use one of three source profiles :
Source | Examples | Characteristics |
|---|---|---|
Root-only | KSM-66 | Most clinically studied |
Root + Leaf | Sensoril, Shoden, NooGandha | Higher withanolide profile |
Root powder (whole) | Traditional | Used in some studies at much higher doses |
Most clinical evidence comes from branded, standardized extracts:
Branded Ingredient | Source | Standardization | Key Studies |
|---|---|---|---|
KSM-66 | Root-only | >5% withanolides | Sleep studies, stress studies |
Sensoril | Root + Leaf | Proprietary | Stress reduction |
Shoden | Root + Leaf | 21 mg withanolide glycosides | Sleep quality |
NooGandha | Root + Leaf | Proprietary | 225/400 mg doses |
Zenroot | Proprietary | 1.5% withanolides | Enhanced bioavailability at 125 mg |
Format | Advantages | Considerations |
|---|---|---|
Capsules | Precise dosing, cost-effective | Most common, well-established |
Gummies | Consumer-friendly, growing popularity | Stability of withanolides in gummy matrix requires testing |
Powders | Dose flexibility | Taste issues, less precise consumer dosing |
Tablets | Precise dosing | Less common for ashwagandha |
Top-tier suppliers maintain:
GMP certification — Current Good Manufacturing Practices
ISO, HACCP, HALAL — Quality and dietary compliance
Third-party testing — Potency, purity, and label accuracy
Heavy metal and pesticide screening — Critical for root-based ingredients
At MINGYAN, we don’t just manufacture supplements — we help brands make informed decisions. Here’s what we consider when developing ashwagandha products:
We recommend matching standardization to your target claim and consumer positioning. For “clinically proven” claims, the 5% withanolide standard (300–600 mg) has the most clinical evidence . For “higher bioavailability / lower dose” positioning, look at the Zenroot model — 125 mg with enhanced delivery . For formulations that require a higher ingredient payload for other actives, an herbal powder approach can work but dosing guidance becomes more critical.
Given the variability in the ashwagandha category — across source material, standardization, and clinical evidence — clarity and transparency are key. We recommend brands:
Specify source and standardization: Clearly list whether extract is root-only, root + leaf, and withanolide percentage.
Use clinically studied ingredients where possible: Branded ingredients like KSM-66 or Sensoril carry their own evidence base.
Manage consumer expectations: Ashwagandha supports stress management, sleep quality, and cognitive function — but it’s not a quick fix.
Gummies are growing rapidly in popularity for their taste and compliance — 51.5% of consumers prefer convenient supplement formats. However, withanolide stability in gummy matrices requires formulation expertise and stability testing. Capsules and powders remain reliable, cost-effective formats for standard extracts.
At MINGYAN, we’re not just manufacturers — we’re your product strategy partner. From ingredient selection to formulation design, we help you build products that deliver real value in this popular but complex category.
Q: What’s the difference between root-only and root+leaf ashwagandha extracts?
A: Root-only extracts (like KSM-66) are traditionally used and have the most clinical evidence. Root+leaf extracts (like Sensoril, Shoden) contain a broader withanolide profile and have also shown efficacy in clinical studies. The choice depends on your brand positioning and target market.
Q: How do I choose the right withanolide percentage?
A: For general wellness positioning with standard dosing, 5% withanolides at 300–600 mg is well-supported by clinical data. For “high potency” or “low dose / high bioavailability” positioning, lower percentage extracts with enhanced delivery systems (like the Zenroot model) offer a newer alternative.
Q: What is the clinical evidence for ashwagandha?
A: Multiple meta-analyses show statistically significant benefits for stress, anxiety, and cortisol reduction . Sleep quality improvements are also supported, particularly at 600 mg/day for 8+ weeks . Evidence for other benefits (muscle strength, cognitive function, fertility) is more preliminary.
Q: Is ashwagandha safe?
A: Clinical studies show ashwagandha is well-tolerated for up to 3 months with mild side effects. Long-term safety is not established. Ashwagandha should be avoided by pregnant women, people with prostate cancer, and those on thyroid, blood pressure, diabetes, or sedative medications without medical supervision.
Q: Can MINGYAN customize ashwagandha formulations?
A: Yes — we offer OEM/ODM services for ashwagandha products, including custom standardization, extraction source selection, delivery formats (gummies, capsules, powders), and proprietary blends with complementary ingredients.
Q: What certifications does MINGYAN hold?
A: MINGYAN holds GMP, ISO, HACCP, and HALAL certifications. We conduct third-party testing for every batch to verify potency, purity, and label accuracy — especially critical for botanicals like ashwagandha.
Q: What does ashwagandha do for stress and anxiety?
A: Research shows ashwagandha may help reduce perceived stress, anxiety, and cortisol levels. A 2024 meta-analysis found significant improvements in stress and anxiety scores compared to placebo after 30–90 days of use .
Q: Does ashwagandha help with sleep?
A: Several studies suggest ashwagandha improves sleep quality, helps people fall asleep faster, and reduces nighttime awakenings. Benefits are more pronounced at 600 mg/day for at least 8 weeks .
Q: How long does it take to see results?
A: Studies show improvements in stress and anxiety can be observed within 30–60 days. Sleep benefits may take longer — up to 8 weeks . Individual results vary.
Q: How much ashwagandha should I take?
A: The World Federation of Societies of Biological Psychiatry (WFSBP) recommends 300–600 mg/day of ashwagandha root extract (5% withanolides) for stress and anxiety . However, optimal dosing depends on formulation and standardization.
Q: Are there side effects?
A: Common side effects include stomach upset, loose stools, nausea, and drowsiness. Ashwagandha may affect thyroid function and liver health in some people. It should not be used by pregnant women or those with prostate cancer.
Q: Can I take ashwagandha every day?
A: Short-term daily use (up to 3 months) appears safe. Long-term safety data is limited, so periodic breaks are recommended .
Q: Does ashwagandha interact with medications?
A: Yes — ashwagandha may interact with thyroid medications, diabetes medications, blood pressure medications, sedatives, and immunosuppressants. Consult a healthcare professional before use.
Whether you‘re a brand seeking custom formulations, a retailer looking for a reliable private label partner, or an entrepreneur ready to launch in this growing category — we’re here to help.
Let‘s start a conversation.
Not sure where to begin? We’ll guide you through standardization options, extraction sources, and formulation choices.
Have a specific claim in mind? We‘ll help you align formulation with clinical evidence.
Need quality assurance? We’ve got you covered — with full GMP, ISO, HACCP, HALAL certifications and third-party testing.
Contact MINGYAN today — and let‘s build something that delivers real value to consumers.
